Thermo Fisher has flourished amid the pandemic, but can it keep the ball rolling when Covid-19 comes to a close?

Amid a gangbusters 12 months for contract manufacturers, Thermo Fisher Scientific saw a massive revenue bump in Q1 — and that’s without considering its $17.4 billion buyout of contract researcher PPD. But Covid-19 won’t last forever, and analysts wonder when and if Thermo Fisher will come back to earth.